XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)
Ordinary Shares [Member]
Class A Ordinary Shares [Member]
Ordinary Shares [Member]
Class B Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Class B Ordinary Shares [Member]
Beginning balance at Dec. 31, 2021   $ 1,006 $ 23,994 $ (15,786) $ 9,214  
Beginning balance (in shares) at Dec. 31, 2021   10,062,500        
Increase (Decrease) in Shareholders' Equity (Deficit) [Roll Forward]            
Accretion for Class A ordinary shares to redemption amount   $ 0 (6,653,994) (26,375,172) (33,029,166)  
Cash in excess of fair value of Private Placement Warrants   0 6,630,000 0 6,630,000  
Net income   0 0 7,104,081 7,104,081  
Ending balance at Mar. 31, 2022   $ 1,006 0 (19,286,877) (19,285,871)  
Ending balance (in shares) at Mar. 31, 2022   10,062,500        
Beginning balance at Dec. 31, 2021   $ 1,006 23,994 (15,786) 9,214  
Beginning balance (in shares) at Dec. 31, 2021   10,062,500        
Increase (Decrease) in Shareholders' Equity (Deficit) [Roll Forward]            
Net income         10,089,869  
Ending balance at Jun. 30, 2022   $ 1,006 0 (16,819,460) (16,818,454)  
Ending balance (in shares) at Jun. 30, 2022   10,062,500        
Beginning balance at Mar. 31, 2022   $ 1,006 0 (19,286,877) (19,285,871)  
Beginning balance (in shares) at Mar. 31, 2022   10,062,500        
Increase (Decrease) in Shareholders' Equity (Deficit) [Roll Forward]            
Accretion for Class A ordinary shares to redemption amount   $ 0 0 (518,371) (518,371)  
Net income   0 0 2,985,788 2,985,788  
Ending balance at Jun. 30, 2022   $ 1,006 0 (16,819,460) (16,818,454)  
Ending balance (in shares) at Jun. 30, 2022   10,062,500        
Beginning balance at Dec. 31, 2022 $ 0 $ 1,006 0 (15,976,998) (15,975,992)  
Beginning balance (in shares) at Dec. 31, 2022 0 10,062,500        
Increase (Decrease) in Shareholders' Equity (Deficit) [Roll Forward]            
Accretion for Class A ordinary shares to redemption amount $ 0 $ 0 0 (2,418,471) (2,418,471)  
Reduction of Deferred Underwriting Fee   0 11,827,938 0 11,827,938  
Net income 0 0 0 851,333 851,333  
Ending balance at Mar. 31, 2023 $ 0 $ 1,006 11,827,938 (17,544,136) (5,715,192)  
Ending balance (in shares) at Mar. 31, 2023 0 10,062,500        
Beginning balance at Dec. 31, 2022 $ 0 $ 1,006 0 (15,976,998) (15,975,992)  
Beginning balance (in shares) at Dec. 31, 2022 0 10,062,500        
Increase (Decrease) in Shareholders' Equity (Deficit) [Roll Forward]            
Net income         2,123,531  
Ending balance at Jun. 30, 2023 $ 999 $ 7 11,827,938 (18,445,856) (6,616,912)  
Ending balance (in shares) at Jun. 30, 2023 9,987,500 75,000       1,312,500
Beginning balance at Mar. 31, 2023 $ 0 $ 1,006 11,827,938 (17,544,136) (5,715,192)  
Beginning balance (in shares) at Mar. 31, 2023 0 10,062,500        
Increase (Decrease) in Shareholders' Equity (Deficit) [Roll Forward]            
Conversion of Class B shares to Class A shares $ 999 $ (999) 0 0 0  
Conversion of Class B shares to Class A shares (in shares) 9,987,500 (9,987,500)        
Accretion for Class A ordinary shares to redemption amount $ 0 $ 0 0 (2,173,918) (2,173,918)  
Net income 0 0 0 1,272,198 1,272,198  
Ending balance at Jun. 30, 2023 $ 999 $ 7 $ 11,827,938 $ (18,445,856) $ (6,616,912)  
Ending balance (in shares) at Jun. 30, 2023 9,987,500 75,000       1,312,500